- See Important Safety Information Below
- Full U.S. Prescribing Information including BOXED WARNING & Medication Guide

Regranex Gel REGRANEX GEL diabetic foot ulcers

 


print page book mark email page
print page book mark email page

 
About REGRANEX Gel


REGRANEX® Gel promotes angiogenesis and granulation tissue formation.


Demonstrates biological activity similar to that of endogenous PDGF


Promotes recruitment and proliferation of chemotactic cells, including monocytes and fibroblasts, necessary for stimulation of a variety of wound healing processes and aiding in the creation of granulation tissue


The first and only prescription growth factor clinically proven to actively stimulate granulation tissue formation and enhance natural wound healing

In clinical trials, when used as an adjunct to good ulcer care practices including initial sharp debridement, pressure relief and infection control; REGRANEX® Gel was shown to increase the incidence and speed of complete healing versus traditional wound therapy for diabetic neuropathic that extended into the subcutaneous tissue and beyond and that had an adequate blood supply.

The efficacy of REGRANEX Gel has not been established for the treatment of pressure ulcers and venous stasis ulcers (see Clinical Studies in Full Prescribing Information), and has not been evaluated for the treatment of diabetic neuropathic ulcers that do not extend through the dermis into subcutaneous tissue (Stage I or II, IAET staging classification) or ischemic diabetic ulcers.